Open letter to Janssen on reducing the price of bedaquiline
MSF joins civil society and many other groups in asking Janssen to reduce the price of their new TB medicine, bedaquiline, which is the first new TB drug to receive approval in 40 years.
TAKE ACTION TO FIX THE TPP
The recent leak of theTrans-Pacific Partnership trade agreement negotiation text confirms our worst fears that access to affordable medicines is in grave danger. Ask the US Government to stop it's attack to affordable medicines »
Help our doctors reach more children
Every year, one in five kids worldwide isn’t fully vaccinated. That’s more than 22 million young lives at risk in one year alone. Our doctors in the field see the consequences every day: children sick and dying of preventable diseases.
Photo © Jose Kendon
Why We Need Open Source Pharma
The current system of developing medicines is inefficient and we often don't get the type of new medicines we need. Open source R&D is key to achieving alternative business models for medicines.
MSF Access Director, Manica Balasegaram, writes on @Medium
What is the Campaign?
Médecins Sans Frontières set up the Access Campaign in 1999 to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond.
Stories from the Field
- » Ethiopia: Tens of thousands of South Sudanese refugees receive cholera vaccine
- » MSF team vaccinated 38,000 children against measles in the Democratic Republic of Congo
- » Surviving drug-resistant TB in Swaziland: "I’m still over the moon”
- » If I had not returned to the clinic in Dawei, I would probably be dead